Nike's fallen on tough times. Now the stock has hit a death cross.
By Steve Goldstein
Nike's stock has been swooshing lower this year.
Nike's stock has entered a pessimistic technical formation called a "death cross," a sign of the tough times the sneaker maker has encountered.
A death cross occurs when the 50-day average of the stock price falls below the 200-day. It can signal a prolonged drop.
Nike's stock (NKE) actually rose Wednesday, but it's down 17% this year, a period in which the S&P 500 SPX has gained 13%.
Even with the decline, it's still more expensive than the typical stock, trading at 30.6 times next 12 month earnings, according to FactSet.
Nike is a victim of tariffs - the company estimated tariffs are now, on an annualized basis, a $1.5 billion drag. It's also been heavily discounting and seen revenue at its Converse brand tumble 27% during its most recent fiscal first quarter.
It's also struggling in China, a key market, where revenue fell 10% last quarter.
Even JPMorgan, which has an overweight rating on Nike, says Wall Street earnings projections for the company's fiscal second half are 25% too high.
Elliott Hill, the company's CEO, said he's focused on improving innovation as well as selling through traditional retailers to boost sales growth.
-Steve Goldstein
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-20-25 0502ET
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for October
14 Elite Funds and ETFs, and 5 Popular Funds That Just Missed the Mark
The 10 Best Companies to Invest in Now
10 Top-Performing US Dividend Stocks
